Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
18.75
-0.61 (-3.18%)
Jan 22, 2026, 12:59 PM EST - Market open
Apollomics Market Cap
Apollomics has a market cap or net worth of $40.24 million as of January 22, 2026. Its market cap has increased by 216.79% in one year.
Market Cap
40.24M
Enterprise Value
40.90M
1-Year Change
216.79%
Ranking
Category
Stock Price
$18.75
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $40.24M, a decrease of -68.95%. That is a compound annual growth rate of -24.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 41.56M | 3.58% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 44.23M |
| Tvardi Therapeutics | 44.09M |
| INmune Bio | 43.60M |
| Jasper Therapeutics | 42.54M |
| TuHURA Biosciences | 41.71M |
| Veru Inc. | 41.57M |
| Actinium Pharmaceuticals | 41.18M |
| Xilio Therapeutics | 40.33M |